NORTHERN TRUST CORP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$102,544
+158.6%
132,0590.0%0.00%
Q4 2022$39,657
-40.8%
132,0590.0%0.00%
Q3 2022$67,000
-13.0%
132,059
-0.9%
0.00%
Q2 2022$77,000
-58.2%
133,264
-6.3%
0.00%
Q1 2022$184,000
+14.3%
142,204
+0.9%
0.00%
Q4 2021$161,000
-26.8%
140,999
-1.7%
0.00%
Q3 2021$220,000
-23.6%
143,428
-1.4%
0.00%
Q2 2021$288,000
+7.5%
145,5150.0%0.00%
Q1 2021$268,000
+92.8%
145,515
+129.5%
0.00%
Q4 2020$139,00063,4020.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders